___ - agents that produce non-ordinary and variable forms of conscious experiences. These include changes in mood, thoughts, and distorted perceptual sensations generally only experienced in dreams
- ___ : has fallen into disfavor as these drugs rarely produce frank hallucinations at doses commonly used
psychedelics
- hallucinogen
delusion
hallucination
illusion
classical psychedelic drugs
derivatives of ___
derivatives of ___
dissociative psychedelic drugs (3)
narurally occuring classical psychedelic drugs
DMT - dimethyltryptamine
- ayahuasca vine
5-MeODMT
- 5-6x > DMT
- colorado river toad
psilocybin
- magic mushrooms, psilocybin is a prodrug of ___
mescaline combines MOA of LSD and MDMA
mescaline
phenethylamine
- amphetamine like - MDMA, bath salts
- increase release of ___ > DA, NE
- empathogens/entactogens
- more ___ than stimulatory
lowest potency (~500 mg)
___ lasting 10-12 hrs
cross tolerance to ___
- suspected interaction with ___ system
most classical psychedelics are agonists of the 5-HT ___ receptor
- pretreatment with antagonists blocks psychedelic effects
- exception: MDMA stimulates ___ release
5-HT2A
5-HT
psychedelic drugs markedly increase ___ integration in the CNS
global
Psychedelic Drug Use AE
short term physiologic
- tachycardia
- HTN
- tremors
- dry mouth
- nausea
- hyperthermia
acute ___ reaction
- terrifying thought
- fear of insanity
- fear of losing control
- fear of death
psychotic reaction
- ___ (hallucinogen persisting perception disorder)
- enduring changes in ___
- exacerbate underlying psychotic disorder
- rate of ___ after LSD 1-5%
Psychedelic Drug Use AE
potential therapeutic uses
shortcomings of clinical trials
- smal sample sice
- lack of inadequate controls
- what is the proper control?
- selection bias (those experienced with or comfortable with psychedelic drug use)
dissociative psychedelics
in contrast to classical psychedelics, dissociatve psychedelics act as antagonists of ____ receptors
1) inhibition of ___ release
2) disinhibition of ___ release
NMDA
1) GABA
2) glutamate
overview of glutamate receptors
prominent NMDA receptor antagonists
ionotropic ___ receptors
- NDMA receptor antagonist
- induce ___ and ___
ketamine
- racemic mixture, ___ (+) enantiomer is more active
- fast/short acting
- ___ recently FDA approved for treatment resistant ___
- used in opioid tolerant patients for chronic pain
___ (DXM)
- also serotonin reuptake inhibitor
- abused by 4% high schoolers
- doses for cough suppression are < 60 mg while 100-600 are used to induce high
PCOL of PCP
1-(1-phenylcyclohexyl) piperidine_
- NDMA ___
- more potent than ___
- also dopamine receptor agonist
severe dissociation and analgesia
- self ___ without recognition (dissociation)
- misuse assocaited with violence and suicude
PCOL of Muscimol
GABA A
allosteric
inhalants
alkyl nitrites
volatile solvents
highest frequency of use among adolescents, especially in isolated communities (access driven)
- ___ : model glues, correction fluids, lacquer thinners, plastic cements, spray paints (most characterized of volatile solvents)
risk of inhalant abuse
sudden ___ death syndrome - development of fatal arrhythmias within minutes of inhalation
- compulsive use
- neurotoxicity
sniffing